Medications Administered Outside Provider-Ordered Parameters Without Documentation or Provider Notification
Summary
The deficiency involves the facility’s failure to administer medications according to provider-ordered parameters for one sampled resident, resulting in services that did not meet professional standards of quality. The resident was admitted with multiple diagnoses including a displaced trimalleolar fracture of the right lower leg, contusion of the lower back and pelvis, anxiety disorder, type 2 diabetes with chronic kidney disease, morbid obesity, major depressive disorder, hypertension, heart failure, orthostatic hypotension, renal insufficiency, and almost constant pain. Care plans initiated in July 2025 addressed hypertension related to CHF and kidney disease, potential for altered comfort/pain related to recent hospitalization, and a right distal fibula fracture, with interventions directing staff to administer antihypertensives and analgesics as ordered. An Admission/Medicare 5‑day MDS showed intact cognition (BIMS 13) and no rejection of care behaviors. For Hydrocodone‑Acetaminophen 5/325 mg ordered PRN every 4 hours for pain rated 6–10/10, the August 2025 MAR showed the medication was administered for pain scores below the ordered threshold, including pain levels of 2, 3, 4, and 5 on multiple dates. For Midodrine 5 mg, 0.5 tablet three times daily with instructions to hold if SBP > 140, the August MAR documented administration when SBP readings exceeded 140 on several occasions. For Sacubitril‑Valsartan 24‑26 mg ordered twice daily with instructions to hold for SBP 110 or HR < 60, the August MAR showed doses given when HR was below 60 on multiple dates. For Metoprolol Tartrate 12.5 mg twice daily ordered to be held for SBP < 110 or HR < 60, the August MAR documented administration when HR was below 60 on several occasions. Progress notes from August 1 through August 31, 2025 contained no documentation explaining why any of these medications were administered outside the ordered parameters or that the provider had been notified. In interviews, an LPN stated that facility policy is to follow provider orders as written, including parameters for blood pressure and pain medications, and that if medications are given outside parameters the provider should be notified and documentation completed. The LPN and the DON both reviewed the clinical record and confirmed multiple instances where Hydrocodone‑Acetaminophen, Midodrine, Sacubitril‑Valsartan, and Metoprolol Tartrate were administered outside provider‑ordered parameters without corresponding documentation or evidence of provider notification. The DON stated that these medications were not administered as ordered, that this did not meet her expectations, and that the clinical record lacked evidence of any provider communication regarding these deviations.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.